PortfoliosLab logo

Cara Therapeutics, Inc. (CARA)

Equity · Currency in USD · Last updated Aug 11, 2022

Company Info

ISINUS1407551092
CUSIP140755109
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$12.56
Year Range$7.45 - $18.14
EMA (50)$9.65
EMA (200)$11.01
Average Volume$491.17K
Market Capitalization$603.97M

CARAShare Price Chart


Chart placeholderClick Calculate to get results

CARAPerformance

The chart shows the growth of $10,000 invested in Cara Therapeutics, Inc. in Feb 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $9,729 for a total return of roughly -2.71%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%MarchAprilMayJuneJulyAugust
20.77%
-4.72%
CARA (Cara Therapeutics, Inc.)
Benchmark (^GSPC)

CARAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M28.16%7.97%
6M19.05%-6.88%
YTD3.12%-11.66%
1Y0.40%-5.01%
5Y-1.94%11.56%
10Y-0.32%10.62%

CARAMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-4.93%-10.45%17.16%-28.23%-4.59%9.74%-4.27%43.71%
202123.60%-1.87%18.31%-40.35%4.94%5.00%-16.12%31.83%-2.09%8.93%-21.69%-7.59%
2020-0.06%-6.65%-12.11%12.19%7.09%7.75%-3.86%-5.72%-17.90%4.20%10.63%3.14%
201917.31%11.80%15.07%-2.75%7.76%4.57%11.35%-2.09%-22.01%13.57%25.14%-37.99%
201819.85%-4.70%-11.44%0.00%26.33%22.44%-6.37%12.49%18.74%-21.75%-2.99%-28.49%
201764.91%4.63%14.72%-13.59%4.22%-7.07%-8.77%2.07%-4.47%-8.40%-0.72%-1.69%
2016-46.62%-45.33%26.42%-1.93%5.90%-25.54%23.28%-8.60%54.06%-16.29%28.76%3.22%
20158.22%-5.00%-1.95%6.97%-11.44%27.63%75.39%-11.03%-24.63%-0.84%16.80%1.87%
201446.24%-1.43%-22.68%-4.24%23.51%-25.09%-19.84%-17.91%7.39%2.55%7.90%

CARASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Cara Therapeutics, Inc. Sharpe ratio is -0.05. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.05
-0.25
CARA (Cara Therapeutics, Inc.)
Benchmark (^GSPC)

CARADividend History


Cara Therapeutics, Inc. doesn't pay dividends

CARADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-56.97%
-12.22%
CARA (Cara Therapeutics, Inc.)
Benchmark (^GSPC)

CARAWorst Drawdowns

The table below shows the maximum drawdowns of the Cara Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Cara Therapeutics, Inc. is 80.50%, recorded on Jun 27, 2016. It took 251 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80.5%Aug 6, 2015225Jun 27, 2016251Jun 26, 2017476
-74.48%Apr 12, 2021273May 9, 2022
-66.16%Jun 29, 2017684Mar 18, 2020264Apr 6, 2021948
-65.5%Mar 6, 2014161Oct 22, 2014197Aug 5, 2015358
-17.89%Feb 3, 20143Feb 5, 20143Feb 10, 20146
-4.33%Feb 19, 20141Feb 19, 20141Feb 20, 20142
-3.87%Feb 11, 20141Feb 11, 20144Feb 18, 20145
-3.47%Feb 24, 20141Feb 24, 20142Feb 26, 20143
-2.28%Apr 7, 20211Apr 7, 20211Apr 8, 20212

CARAVolatility Chart

Current Cara Therapeutics, Inc. volatility is 87.22%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%MarchAprilMayJuneJulyAugust
87.22%
16.23%
CARA (Cara Therapeutics, Inc.)
Benchmark (^GSPC)